FSHB rs12214197: Reproductive Timing and Hormone Regulation
The rs12214197 polymorphism is a single-nucleotide variant located upstream of the FSHB gene on chromosome 11. It is situated in a regulatory region implicated in modulating the transcription of the follicle-stimulating hormone beta subunit. Published research associates variation in this locus with subtle shifts in reproductive timing, including the ages of menarche and natural menopause.
What each genotype means
Typical FSHB promoter activity
This genotype represents the major allele configuration associated with standard baseline levels of follicle-stimulating hormone (FSH) production. Research indicates that individuals with this genotype generally exhibit higher serum FSH levels compared to those carrying the T allele. This is considered the common, expected profile in most populations.
Carried by approximately 76% of individuals in European cohorts, where it is the most prevalent genotype.
Reduced FSHB promoter activity
Carrying one copy of the T allele is associated with a measurable decrease in serum FSH levels compared to the GG genotype. This variant is located in a regulatory region of the FSHB gene, and research suggests it may influence the efficiency of hormone transcription. If you have concerns regarding reproductive health or hormone levels, please discuss these findings with a qualified clinician or endocrinologist.
Observed in approximately 23% of individuals in European populations.
Lower FSHB promoter activity
This genotype is associated with the lowest observed serum FSH levels in studies of this variant. The T allele is linked to a potential reduction in FSHB biosynthesis, which in some research contexts has been investigated as a contributing factor to isolated FSH deficiency or impaired spermatogenesis in men. Because this association is based on statistical trends in specific cohorts, please consult with a healthcare provider to interpret these results in the context of your personal health history.
A rare genotype, found in approximately 1% of individuals in European populations.
Genetic Location and Genomic Context
The single-nucleotide polymorphism rs12214197 is positioned on the short arm of chromosome 11 (11p14.1) within the non-coding upstream region of the FSHB gene. Because it lies upstream of the primary coding sequence, rs12214197 does not alter the amino acid sequence of the resulting protein. Instead, variants in this promoter and regulatory territory often influence the binding efficiency of transcription factors or alter regional chromatin accessibility. The upstream region of FSHB contains several evolutionary conserved regulatory elements that coordinate hormone production in the anterior pituitary. Genetic variations located within this genomic window are frequently evaluated in linkage disequilibrium studies alongside neighboring regulatory markers, such as the well-studied promoter variant rs10835638, to understand how non-coding architecture influences human endocrine physiology.
The Role of the FSHB Gene in Human Biology
The FSHB gene encodes the beta subunit of follicle-stimulating hormone (FSH), a pituitary glycoprotein essential for normal mammalian reproduction. While FSH shares an identical alpha subunit with luteinizing hormone (LH), thyroid-stimulating hormone (TSH), and chorionic gonadotropin (hCG), the beta subunit is unique to FSH and dictates its biological specificity. The synthesis of the beta subunit is the rate-limiting step in assembling the mature, dimeric FSH hormone. In females, circulating FSH drives the growth and recruitment of ovarian follicles, stimulates granulosa cell proliferation, and triggers estrogen production during the early follicular phase of the menstrual cycle. In males, FSH acts on testicular Sertoli cells to support spermatogenesis. Consequently, subtle variations in FSHB expression can affect baseline serum hormone concentrations, ovarian folliculogenesis, and overall reproductive longevity.
Current Scientific Evidence and Reproductive Traits
Genome-wide association studies (GWAS) and reproductive genetics consortia have identified the FSHB upstream region as a modulator of female endocrine milestones. Research indicates that alleles in this locus influence the timing of both menarche and menopause, as well as the length of the menstrual cycle. Modest statistical shifts of a few months in the timing of natural menopause have been observed across cohort analyses, likely reflecting altered rates of follicular depletion due to variations in circulating FSH levels. However, the direct clinical evidence for rs12214197 specifically remains classified as limited. Many recorded associations represent locus-wide linkage signals where this marker correlates with nearby functional promoter variants. Furthermore, the effect sizes detected in population studies are small, meaning this single variant accounts for only a minor fraction of the total phenotypic variance in reproductive timing.
Interpreting Genetic Findings Responsibly
It is essential to understand that rs12214197 is a common population variant associated with subtle physiological trends, not a diagnostic marker for infertility or endocrine disorders. Carrying a particular genotype does not guarantee an early or late onset of menopause, nor does it predict personal fertility outcomes. Reproductive timelines and conditions such as polycystic ovary syndrome (PCOS) or endometriosis are polygenic and heavily modulated by lifestyle, nutrition, environmental exposures, and overall health. Genetic test results detailing rs12214197 should be viewed purely as educational insights into human endocrine variation. Individuals with questions regarding family planning, irregular menstrual cycles, or menopausal management should consult a qualified healthcare provider or reproductive endocrinologist rather than relying on individual genomic polymorphisms.
How common is this variant?
The minor allele frequency for rs12214197 varies across ancestral backgrounds, documented at approximately 0.15 in European populations and roughly 0.05 in East Asian populations according to genomic reference databases.
Frequently asked questions
Does my rs12214197 genotype predict when I will start menopause?
No. While variants near the FSHB gene show modest statistical associations with the age of natural menopause in large population studies, the individual effect size is very small. Timing of menopause is influenced by hundreds of genetic loci alongside lifestyle and environmental factors.
Can rs12214197 cause infertility?
There is no scientific evidence that rs12214197 alone causes female or male infertility. It is a common regulatory variant associated with subtle differences in hormone levels rather than severe monogenic reproductive dysfunction.
How does this variant affect follicle-stimulating hormone (FSH)?
The variant sits upstream in the regulatory region of the FSHB gene, which produces the beta subunit that controls overall FSH production. Variants in this upstream promoter region may slightly alter gene transcription, leading to modest variations in circulating FSH levels.
Should I change any medical treatments based on this SNP?
No, you should never alter any medication, hormone therapy, or fertility treatment based on this genetic result. Variant associations at rs12214197 are purely observational and lack direct clinical utility for medical decision-making.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12214197?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FSHB
Promoter-adjacent variant linked to FSHB expression, influencing basal follicle-stimulating hormone levels, menstrual cycle duration, and twinning propensity.
Pathogenic loss-of-function variant causing isolated follicle-stimulating hormone deficiency leading to hypogonadotropic hypogonadism.
Functional promoter variant in FSHB influencing serum FSH concentrations and reproductive lifespan.
Variant in the promoter region of FSHB associated with circulating follicle-stimulating hormone levels, age at menarche, and reproductive lifespan.
Located in the promoter of FSHB (c.-211G>T), this variant downregulates follicle-stimulating hormone transcription and is strongly associated with male infertility traits (oligozoospermia) and altered female reproductive lifespan.
Variant in the promoter region of FSHB associated with altered follicle-stimulating hormone levels, timing of menarche, and female reproductive lifespan.